GNH USA

Europe — EMA

Palandra (Drospirenone, Ethinylestradiol)

Drospirenone, the active ingredient in Palandra, is a combined hormonal contraceptive presented as a tablet for oral use. It is used to prevent pregnancy in women of reproductive age.

Request sourcing

1
Pack/s

What is Drospirenone, Ethinylestradiol?

Drospirenone, the active ingredient in Palandra, is a combined hormonal contraceptive presented as a tablet for oral use. It is used to prevent pregnancy in women of reproductive age. GNH USA supplies Palandra as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Palandra as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Drospirenone, Ethinylestradiol used for?

Palandra is a combined oral contraceptive that acts on the hormonal regulation pathway to prevent ovulation.

- Contraception: Provides reliable prevention of pregnancy when taken as directed. - Menstrual Cycle Regulation: Helps to establish more predictable menstrual bleeding patterns. - Acne Management: May improve acne symptoms associated with hormonal fluctuations.

What are the side effects of Drospirenone, Ethinylestradiol?

Common  ​ ​ ​ ​  …  … ​ …  ....  …  … ...  

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Drospirenone, Ethinylestradiol
Route
Oral Use
Manufacturer
Bayer B.V.
Origin
EU

Related products